Australia markets close in 1 hour 22 minutes

Gyre Therapeutics, Inc. (GYRE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.72-0.36 (-2.98%)
At close: 01:00PM EDT
11.61 -0.11 (-0.94%)
After hours: 02:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.00B
Enterprise value 965.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.65
Price/book (mrq)17.69
Enterprise value/revenue 8.34
Enterprise value/EBITDA 44.12

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3129.80%
S&P500 52-week change 325.51%
52-week high 330.40
52-week low 34.80
50-day moving average 312.80
200-day moving average 314.85

Share statistics

Avg vol (3-month) 376.85k
Avg vol (10-day) 3146.35k
Shares outstanding 585.51M
Implied shares outstanding 685.51M
Float 815.72M
% held by insiders 181.73%
% held by institutions 10.99%
Shares short (14 June 2024) 4189.07k
Short ratio (14 June 2024) 43.15
Short % of float (14 June 2024) 42.95%
Short % of shares outstanding (14 June 2024) 40.22%
Shares short (prior month 15 May 2024) 4169.64k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 312 Jan 2023
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 331 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -75.76%
Operating margin (ttm)29.70%

Management effectiveness

Return on assets (ttm)11.03%
Return on equity (ttm)-99.09%

Income statement

Revenue (ttm)115.69M
Revenue per share (ttm)1.63
Quarterly revenue growth (yoy)9.00%
Gross profit (ttm)N/A
EBITDA 21.87M
Net income avi to common (ttm)-87.64M
Diluted EPS (ttm)-1.03
Quarterly earnings growth (yoy)235.70%

Balance sheet

Total cash (mrq)37.35M
Total cash per share (mrq)0.44
Total debt (mrq)275k
Total debt/equity (mrq)0.31%
Current ratio (mrq)3.22
Book value per share (mrq)0.66

Cash flow statement

Operating cash flow (ttm)18.36M
Levered free cash flow (ttm)N/A